Table 1.
Sensitivity analyses of efficacy of CHM compared with WM in AG
| Number of studies | Number of subjects | RR | 95% CI | I2 value | |
|---|---|---|---|---|---|
| Eradication rate of H. pylori | |||||
| CHM (alone or integrated with WM) versus WM | 5 | 544 | 1.16 | [0.96, 1.41] | 66% |
| CHM versus WM | 5 | 544 | 1.16 | [0.96, 1.41] | 66% |
| Int. CHM-WM versus WM | 0 | 0 | N/A | N/A | N/A |
| Clinical manifestations improvement | |||||
| CHM (alone or integrated with WM) versus WM | 20 | 2,213 | 1.27 | [1.22, 1.33] | 12% |
| CHM versus WM | 16 | 1,939 | 1.29 | [1.23, 1.36] | 10% |
| Int. CHM-WM versus WM | 4 | 274 | 1.18 | [1.07, 1.31] | 0% |
| Pathological improvement | |||||
| CHM (alone or integrated with WM) versus WM | 12 | 1,284 | 1.44 | [1.27, 1.63] | 60% |
| CHM versus WM | 9 | 1,092 | 1.35 | [1.20, 1.52] | 53% |
| Int. CHM-WM versus WM | 3 | 192 | 1.87 | [1.42, 2.45] | 0% |